| 11249711
|
AG-7088 Pfizer. |
Curr Opin Investig Drugs |
2000 |
Witherell G |
View
More |
| 15170592
|
Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules. |
Med Res Rev |
2004 |
Shih SR;Chen SJ;Hakimelahi GH;Liu HJ;Tseng CT;Shia KS |
View
More |
| 16111680
|
Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. |
FEBS Lett |
2005 |
Harper RW;Xu C;Eiserich JP;Chen Y;Kao CY;Thai P;Setiadi H;Wu R |
View
More |
| 16199099
|
Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril. |
Antiviral Res |
2005 |
Ledford RM;Collett MS;Pevear DC |
View
More |
| 1666824
|
A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program. |
Antiviral Res |
1991 |
Andries K;Dewindt B;Snoeks J;Willebrords R;Stokbroekx R;Lewi PJ |
View
More |
| 16675037
|
Rhinovirus chemotherapy. |
Antiviral Res |
2006 |
Patick AK |
View
More |
| 20974282
|
Developments towards antiviral therapies against enterovirus 71. |
Drug Discov Today |
2010 |
Wu KX;Ng MM;Chu JJ |
View
More |
| 22808255
|
Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes. |
PLoS One |
2012 |
Proud D;Hudy MH;Wiehler S;Zaheer RS;Amin MA;Pelikan JB;Tacon CE;Tonsaker TO;Walker BL;Kooi C;Traves SL;Leigh R |
View
More |
| 228594
|
RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compound. |
Antimicrob Agents Chemother |
1979 |
Ash RJ;Parker RA;Hagan AC;Mayer GD |
View
More |
| 2555523
|
Crystal structure of human rhinovirus serotype 1A (HRV1A). |
J Mol Biol |
1989 |
Kim SS;Smith TJ;Chapman MS;Rossmann MC;Pevear DC;Dutko FJ;Felock PJ;Diana GD;McKinlay MA |
View
More |
| 2676677
|
Neutralization of small RNA viruses by antibodies and antiviral agents. |
FASEB J |
1989 |
Rossmann MG |
View
More |
| 28581456
|
Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition. |
Nat Microbiol |
2017 |
Yang J;Tian B;Sun H;Garofalo RP;Brasier AR |
View
More |
| 3018924
|
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. |
Science |
1986 |
Smith TJ;Kremer MJ;Luo M;Vriend G;Arnold E;Kamer G;Rossmann MG;McKinlay MA;Diana GD;Otto MJ |
View
More |
| 3026048
|
The atomic structure of Mengo virus at 3.0 A resolution. |
Science |
1987 |
Luo M;Vriend G;Kamer G;Minor I;Arnold E;Rossmann MG;Boege U;Scraba DG;Duke GM;Palmenberg AC |
View
More |
| 33356169
|
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2. |
Bioconjug Chem |
2021 |
Larue RC;Xing E;Kenney AD;Zhang Y;Tuazon JA;Li J;Yount JS;Li PK;Sharma A |
View
More |
| 33606112
|
Lactoferrin affects rhinovirus B-14 entry into H1-HeLa cells. |
Arch Virol |
2021 |
Denani CB;Real-Hohn A;de Carvalho CAM;Gomes AMO;Goncalves RB |
View
More |
| 35413355
|
Eosinophil-mediated suppression and anti-IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma. |
J Allergy Clin Immunol |
2022 |
Dill-McFarland KA;Schwartz JT;Zhao H;Shao B;Fulkerson PC;Altman MC;Gill MA |
View
More |
| 36041223
|
Conditionally reprogrammed asthmatic bronchial epithelial cells express lower <i>FOXJ1</i> at terminal differentiation and lower <i>IFNs</i> following RV-A1 infection. |
Am J Physiol Lung Cell Mol Physiol |
2022 |
Veerati PC;Nichol KS;Read JM;Bartlett NW;Wark PAB;Knight DA;Grainge CL;Reid AT |
View
More |
| 36341332
|
Rhinovirus-induced anti-viral interferon secretion is not deficient and not delayed in sinonasal epithelial cells of patients with chronic rhinosinusitis with nasal polyp. |
Front Immunol |
2022 |
Lee SH;Han MS;Lee TH;Lee DB;Park JH;Lee SH;Kim TH |
View
More |
| 36762857
|
Cryo-EM reveals binding of linoleic acid to SARS-CoV-2 spike glycoprotein, suggesting an antiviral treatment strategy. |
Acta Crystallogr D Struct Biol |
2023 |
Toelzer C;Gupta K;Berger I;Schaffitzel C |
View
More |
| 4313024
|
Antiviral action of gliotoxin. |
Arch Gesamte Virusforsch |
1969 |
McDougall JK |
View
More |
| 7473717
|
Structural studies on human rhinovirus 14 drug-resistant compensation mutants. |
J Mol Biol |
1995 |
Hadfield AT;Oliveira MA;Kim KH;Minor I;Kremer MJ;Heinz BA;Shepard D;Pevear DC;Rueckert RR;Rossmann MG |
View
More |
| 7741521
|
In vivo efficacy of SDZ 35-682, a new picornavirus capsid-binding agent. |
Antiviral Res |
1995 |
Rosenwirth B;Kis ZL;Eggers HJ |
View
More |
| 7811059
|
Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses. |
Antiviral Res |
1994 |
Dewindt B;van Eemeren K;Andries K |
View
More |
| 7994569
|
Structure-based drug design of antirhinoviral compounds. |
Structure |
1994 |
Giranda VL |
View
More |
| 8101071
|
Functional studies of truncated soluble intercellular adhesion molecule 1 expressed in Escherichia coli. |
Antimicrob Agents Chemother |
1993 |
Martin S;Martin A;Staunton DE;Springer TA |
View
More |
| 8391247
|
SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. |
Antiviral Res |
1993 |
Rozhon E;Cox S;Buontempo P;O'Connell J;Slater W;De Martino J;Schwartz J;Miller G;Arnold E;Zhang A;et al. |
View
More |
